1. Diverse antitumor effects of ascorbic acid on cancer cells and the tumor microenvironment
   Takeru Maekawa et al, 2022, Frontiers in Oncology CrossRef
2. Metabolic barriers in non-small cell lung cancer with LKB1 and/or KEAP1 mutations for immunotherapeutic strategies
   Ichidai Tanaka et al, 2023, Frontiers in Oncology CrossRef
3. CPNE1 Enhances Colorectal Cancer Cell Growth, Glycolysis, and Drug Resistance Through Regulating the AKT-GLUT1/HK2 Pathway
   Yuexia Wang et al, 2021, OncoTargets and Therapy CrossRef
4. Linking Metabolic Reprogramming, Plasticity and Tumor Progression
   Oleg Shuvalov et al, 2021, Cancers CrossRef
5. Conformational Studies of Glucose Transporter 1 (GLUT1) as an Anticancer Drug Target
   Suliman Almahmoud et al, 2019, Molecules CrossRef
6. Heterogeneity of Glucose Transport in Lung Cancer
   Cesar A. Martinez et al, 2020, Biomolecules CrossRef
7. Deregulated SLC2A1 Promotes Tumor Cell Proliferation and Metastasis in Gastric Cancer
   Shiyan Yan et al, 2015, International Journal of Molecular Sciences CrossRef
8. Epigenetic and metabolic interplay in cutaneous squamous cell carcinoma
   Gina Pacella et al, 2021, Experimental Dermatology CrossRef
9. Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes
   Alexandru Andrei Tirpe et al, 2019, International Journal of Molecular Sciences CrossRef
10. Glucose transporters as markers of diagnosis and prognosis in cancer diseases
    Leszek Szablewski, 2022, Oncology Reviews CrossRef